MAALOX SUSPENZE

Main information

  • Trade name:
  • MAALOX SUSPENZE Oral suspension 35MG/ML+40MG/ML
  • Dosage:
  • 35MG/ML+40MG/ML
  • Pharmaceutical form:
  • Oral suspension
  • Administration route:
  • Oral use
  • Units in package:
  • 1X250ML II Bottle
  • Prescription type:
  • OTC medicinal products
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • MAALOX SUSPENZE Oral suspension 35MG/ML+40MG/ML
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • COMBINATIONS AND COMPLEXES OF COMPOUNDS OF ALUMINIUM, CALCIUM AND MAGNESIUM
  • Product summary:
  • MAALOX SUSPENZE

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 09/ 272/92-C
  • Authorization date:
  • 16-02-2018
  • EAN code:
  • 8595187813038
  • Last update:
  • 05-04-2018

4-5-2009

Consultation on the reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

Consultation on the reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

At the Danish Medicines Agency's request, the Reimbursement Committee has reassessed the reimbursement status of medicinal products authorised for marketing in Denmark in ATC group A06 (laxatives) and A02AA04 (magnesium hydroxide)

Danish Medicines Agency

22-10-2018

Velphoro (Vifor Fresenius Medical Care Renal Pharma France)

Velphoro (Vifor Fresenius Medical Care Renal Pharma France)

Velphoro (Active substance: mixture of polynuclear iron(iii)-oxyhydroxide, sucrose and starches) - Centralised - Yearly update - Commission Decision (2018)6972 of Mon, 22 Oct 2018

Europe -DG Health and Food Safety